(VIANEWS) – The Market ended the session with NYXOAH (NYXH.BR) rising 11.59% to €16.85 on Monday, following the last session’s downward trend. BEL 20 dropped 0.3% to €3,673.19, after three consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.
NYXOAH’s last close was €15.10, 5.63% below its 52-week high of €16.00.
About NYXOAH
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-1.68.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.58%.
Yearly Top and Bottom Value
NYXOAH’s stock is valued at €16.85 at 21:32 EST, above its 52-week high of €16.00.
Volume
Today’s last reported volume for NYXOAH is 40529 which is 40.92% below its average volume of 68603.
More news about NYXOAH (NYXH.BR).
